- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02989051
Fluid Restriction Keeps Children Dry (LESSER)
Fluids in Mechanically Ventilated Children With Acute Infectious Lung Disease: How Dry Should They be?
Rationale: Fluid overload is a common complication in children who are admitted to the pediatric intensive care for mechanical ventilation. Acute lung infection is a frequent cause for admission to the PICU and forms an uniform group with a single organ failure. In these critically ill children, fluid overload is associated with adverse outcome. Restricting the volume of fluids already in an early stage of ICU admission may prevent fluid overload during mechanical ventilation and thus improve clinical outcome. However, at the same time fluid restriction may interfere with appropriate energy and macronutrient intake that is needed for recovery.
Objective: The main goal of this pilot study is to evaluate the feasibility of a restrictive fluid management protocol and investigate its effect on the occurrence of fluid overload in mechanically ventilated children with acute infectious lung disease.
Study design: Single-center prospective randomized feasibility and pilot study in preparation of a multi-center randomized controlled trial (RCT).
Study population: Mechanically ventilated children with (suspicion of) acute infectious lung disease admitted to the pediatric intensive care unit (PICU) of the Emma Children's Hospital, Academic Medical Center, Amsterdam.
Intervention: Patients receive either liberal (control group) or a restrictive (experimental group) fluid treatment, while ensuring appropriate caloric intake.
Main study parameters/endpoints: Primary outcomes are cumulative fluid balance and body weight during the first week of mechanical ventilation. Secondary outcomes (in preparation of the larger multi-center RCT) include: mortality, duration of mechanical ventilation and oxygenation indices. To determine the feasibility, in- and exclusion rate, adherence to treatment arms, need for fluid bolus, need for diuretics and hemodynamic indices as well as energy and protein intake are studied.
Both fluid management protocols reflect a variant of current clinical practice, hence will not provide extra burden or risk to patients included in the study. Patients will be randomized to either of the fluid protocol arms on admission to the PICU (at start of mechanical ventilation). Patients included in the restrictive fluid treatment arm might have direct benefit from the study if indeed fluid overload is less common in this group.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Amsterdam, Netherlands
- Recruiting
- Academic Medical Center
-
Contact:
- Sarah A Ingelse, MD
- Phone Number: 0031-20-5665675
- Email: s.a.ingelse@amc.nl
-
Contact:
- Job BM van Woensel, Professor
- Phone Number: 0031-20-566579
- Email: ic.kinderen@amc.nl
-
Sub-Investigator:
- Sarah A Ingelse, MD
-
Sub-Investigator:
- Reinout A Bem, MD PhD
-
Principal Investigator:
- Job BM van Woensel, Professor (MD PhD)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Signed informed consent by parents or legal caretakers
- Admitted to the PICU of the Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands
- Intubated and mechanically ventilated, with an anticipated duration of mechanical ventilation of at least 72 hours at enrolment (as judged by investigator or pediatrician on duty)
- Patients with an acute infectious lung disease, including (suspected) viral, bacterial or fungal infection
Exclusion Criteria:
- Patients in need of a particular fluid regimen (either restrictive or liberal) due to their medical history (e.g. cardiovascular disease and/or congenital (cyanotic) heart disease)
- Use of previous and/or maintenance diuretic treatment
- Ongoing (fluid) resuscitation on admission
- Acute kidney injury with need for renal replacement therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Restrictive fluid treatment
Restrictive fluid regimen
|
In this treatment arm, patients will receive a maximal daily fluid intake of 70% of normal requirements (for a healthy child).
|
|
ACTIVE_COMPARATOR: Liberal fluid treatment
This is seen as current standard clinical treatment, wherein patients will receive a more liberal fluid regimen.
|
This is considered current standard clinical treatment, wherein patients will receive a fluid regimen of >85% of normal fluid recommendations (for a healthy child).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cumulative fluid balance
Time Frame: First week of mechanical ventilation
|
First week of mechanical ventilation
|
|
Body weight
Time Frame: First week of mechanical ventilation
|
First week of mechanical ventilation
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Duration of mechanical ventilation
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Oxygenation indices
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Mortality
Time Frame: Up to 90 days after admission
|
Up to 90 days after admission
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
In- and exclusion rate
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Adherence to treatment arms
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Need for fluid bolus
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Need for diuretics
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Need for vasopressors or inotropic drugs
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Energy and protein intake
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Gastrointestinal complaints
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Hemodynamic indices
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
|
Occurrence of electrolyte imbalances
Time Frame: Through study completion, an average of 1 week
|
Through study completion, an average of 1 week
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016_096
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.